This map shows the geographic impact of Santwana Kar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santwana Kar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santwana Kar more than expected).
This network shows the impact of papers produced by Santwana Kar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santwana Kar. The network helps show where Santwana Kar may publish in the future.
Co-authorship network of co-authors of Santwana Kar
This figure shows the co-authorship network connecting the top 25 collaborators of Santwana Kar.
A scholar is included among the top collaborators of Santwana Kar based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Santwana Kar. Santwana Kar is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Kar, Santwana & Santosh K. Kar. (2010). Control of malaria. Nature Reviews Drug Discovery. 9(7). 511–512.22 indexed citations
2.
Yasothan, Uma & Santwana Kar. (2008). Osteoporosis: overview and pipeline. Nature Reviews Drug Discovery. 7(9). 725–726.28 indexed citations
3.
Yasothan, Uma & Santwana Kar. (2008). Therapies for COPD. Nature Reviews Drug Discovery. 7(4). 285–286.15 indexed citations
4.
Burton, Barbara K., Santwana Kar, & Peter J. Kirkpatrick. (2008). Sapropterin. Nature Reviews Drug Discovery. 7(3). 199–200.2 indexed citations
5.
Moy, Beverly, Peter Kirkpatrick, Santwana Kar, & Paul E. Goss. (2007). Lapatinib. Nature Reviews Drug Discovery. 6(6). 431–432.127 indexed citations
6.
Rini, Brian I., Santwana Kar, & Peter Kirkpatrick. (2007). Temsirolimus. Nature Reviews Drug Discovery. 6(8). 599–600.28 indexed citations
7.
Daum, Robert S., Santwana Kar, & Peter J. Kirkpatrick. (2007). Retapamulin. Nature Reviews Drug Discovery. 6(11). 865–866.55 indexed citations
8.
Siragy, Helmy M., Santwana Kar, & Peter Kirkpatrick. (2007). Aliskiren. Nature Reviews Drug Discovery. 6(10). 779–780.8 indexed citations
9.
Conlin, Alison, Monica Fornier, Clifford A. Hudis, Santwana Kar, & Peter Kirkpatrick. (2007). Ixabepilone. Nature Reviews Drug Discovery. 6(12). 953–954.43 indexed citations
10.
Parker, Charles J., Santwana Kar, & Peter J. Kirkpatrick. (2007). Eculizumab. Nature Reviews Drug Discovery. 6(7). 515–516.35 indexed citations
11.
Newman, John H., Santwana Kar, & Peter J. Kirkpatrick. (2007). Ambrisentan. Nature Reviews Drug Discovery. 6(9). 697–698.9 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.